Biopharma sponsors and CROs now have access to a modern eCOA solution that seamlessly integrates a configurable, no-code platform with validated cognitive assessments and deep clinical expertise CARY, N.C. , July 23, 2024 /PRNewswire/ -- Thread, a leading decentralized research and electronic clinical outcome assessment (eCOA) provider, today announced a collaboration with cognitive science leaders Cogstate Limited (ASX:CGS).
The partnership combines Cogstate's best-in-class clinical and cognitive science solutions in digital assessment, endpoint data quality, remote assessments services, and deep experience in central nervous system (CNS) disorders with Thread's next-generation, proprietary no-code configurable eCOA platform including telehealth, engagement solutions and click-to-add assessment library. The partnership combines Cogstate's best-in-class clinical and cognitive science solutions in digital assessment, endpoint data quality, remote assessment services, and deep experience in central nervous system (CNS) disorders with Thread's next-generation, proprietary no-code configurable eCOA platform including telehealth, engagement solutions and click-to-add assessment library. Biopharma companies and CROs are seeking new offerings to deploy complex eCOA that leverages proven scientific expertise and next-generation technology to make the collection of high-quality CNS endpoints easier for both patients and research sites.
This joint solution offers an integrated delivery.